A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Clinical trial NCT05961111 · UNKNOWN

Trial details

NCT number: NCT05961111
Sponsor: Shanghai Yunying Medical Technology
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Sarcoma Carcinoma Digestive Cancer Breast Cancer Lung Cancer Brain Cancer Melanoma Gynecologic Cancer Head and Neck Cancer Kidney Cancer

Start date: 2023-06-24
Primary completion: 2025-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.